Form 4: Cadre Holdings CEO and Chairman Warren B. Kanders Sells Over 125,000 Shares Under 10b5-1 Plan

Cadre Holdings, Inc.'s CEO and Chairman, Warren B. Kanders, reported the sale of 125,000 shares of common stock for approximately $4.2 million in early June, as part of a pre-arranged trading plan.

Summary

• Warren B. Kanders, who serves as CEO, Chairman, Director, and a 10% owner of Cadre Holdings, Inc. (CDRE), reported two separate sales of the company's common stock.
• On June 3, 2025, Mr. Kanders sold 100,000 shares at a weighted average price of $33.51 per share, generating approximately $3,351,000. The individual sale prices for this transaction ranged from $33.09 to $33.88 per share.
• On June 4, 2025, an additional 25,000 shares were sold at a weighted average price of $33.99 per share, totaling approximately $849,750. These shares were sold within a price range of $33.86 to $34.15 per share.
• The combined total of shares sold across both transactions amounts to 125,000 shares.
• These transactions were executed pursuant to a Rule 10b5-1(c) trading plan, indicating they were pre-scheduled and not based on new, non-public information.
• Following these sales, Warren B. Kanders beneficially owns a total of 11,715,876 shares of Cadre Holdings Common Stock. This includes 45,584 shares held directly, 10,341,192 shares held indirectly through Kanders SAF, LLC, 1,305,650 shares through Warren B. Kanders Roth IRA, and 23,450 shares through Allison Kanders Roth IRA (spouse).

Sentiment

Score: 5

Explanation: The sentiment is neutral. While insider selling can be perceived negatively, the sales were conducted under a Rule 10b5-1 plan, which suggests they were pre-scheduled and not based on new, adverse information. The amount sold is also a relatively small percentage (~1.07%) of the insider's total beneficial holdings, further mitigating a strong negative signal.

Positives

• The sales were conducted under a Rule 10b5-1 trading plan, which suggests the transactions were pre-scheduled and not based on new, adverse non-public information, potentially mitigating negative market interpretations.
• The shares were sold at relatively high prices, ranging from $33.09 to $34.15 per share, indicating the insider capitalized on favorable market conditions.

Negatives

• A significant insider sale by the CEO, Chairman, and a 10% owner, totaling approximately $4.2 million, could be perceived negatively by the market, potentially signaling a lack of confidence or a desire for diversification.

Risks

• Potential negative market perception due to insider selling, which could lead to downward pressure on the company's stock price, despite the Rule 10b5-1 plan.

Future Outlook

The document does not provide any forward-looking statements or guidance regarding the company's future performance or strategic direction, focusing solely on insider trading activity.

Industry Context

This Form 4 filing reports an insider transaction, which is a routine disclosure for publicly traded companies. While it doesn't directly relate to broader industry trends, significant insider selling or buying can sometimes be interpreted by the market as a signal about the company's internal prospects relative to its industry peers. However, given the Rule 10b5-1 plan, the signal is mitigated.

Comparison to Industry Standards

• This document reports an insider trading activity, which is a standard disclosure requirement for all publicly traded companies under SEC regulations.
• There are no specific financial results or operational metrics to compare against industry benchmarks or specific comparable companies/projects within this filing.
• The key comparison point is the adherence to regulatory filing requirements and the use of a Rule 10b5-1 plan, which is a common and accepted practice for insiders to manage stock sales in a compliant manner, aligning with corporate governance best practices.

Stakeholder Impact

• Shareholders may interpret the insider selling as a negative signal, potentially leading to a decrease in investor confidence, although the Rule 10b5-1 plan mitigates this concern.
• Employees, customers, suppliers, and creditors are unlikely to be directly impacted by this specific insider trading report, as it does not pertain to operational or strategic changes.

Next Steps

• The document does not outline any specific future actions, events, or milestones for the company, as it is solely focused on reporting insider stock transactions.

Key Dates

Recommendation

Keywords

Cadre Holdings, CDRE, Insider Selling, Form 4, Warren B. Kanders, Stock Sale, Beneficial Ownership, Rule 10b5-1, CEO, Chairman